Learn More
Medchemexpress LLC Sobetirome (GC-1) | 211110-63-3 | 99.85% and 99.91% | 328.40 | 100 MG

Supplier: Medchemexpress LLC HY14823100MG
Sobetirome (GC-1) is a thyroid hormone receptor β (TRβ)-specific agonist. It selectively binds to TRβ-1 with an EC50 of 0.16 μM and is also a liver uptake-selective agonist. This product is intended for research use only.
- Thyroid hormone receptor β (TRβ)- and liver uptake-selective agonist.
- Reduces high-density lipoprotein (HDL) cholesterol and very low-density lipoprotein (VLDL) triglyceride levels in euthyroid mice.
- Reduces HDL cholesterol and triglyceride levels in hypercholesterolemic mice.
- Increases hepatic HDL receptors and stimulates bile acid synthesis in hypercholesterolemic mice.
- Treatment with 10x Sobetirome results in a fat mass gain of only 21% (1.7 g).
- Treatment with 20x Sobetirome induces a decrease in fat mass of 20% (1.3 g).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.